NCT01080677View on ClinicalTrials.gov

Caffeine/Propranolol Intervention for Acute Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions
Migraine Disorders
Interventions
DRUG

caffeine/propranolol combination tablet

caffeine/propranolol combination tablet administered orally once daily

DRUG

placebo

placebo to match caffeine/propranolol combination tablet administered orally once daily

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01080677 - Caffeine/Propranolol Intervention for Acute Migraine | Biotech Hunter | Biotech Hunter